TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CRMD

CorMedix Inc

Healthcare · Biotechnology

7.90$ +1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CRMD
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– +0.0% +69.8% +44.1% +101.2% -1.3% +74.6% -51.6% +36.7% -16.4% +338.1% +4,593.2%
– +48.8% -58.6% +24.3% -33.1% +119.7% +2.5% +101.7% -19.3% +35.0% +11.6% +125.7%
– -70.5% -56.3% +3.0% -26.4% +122.1% +3.8% +97.0% -16.8% – – –
– +169.3% +48.2% +224.1% -32.4% -199.5% – – -41.9% +109.2% -1,866.9% –
– -39.2% +280.2% +158.8% -67.8% -25.2% +208.0% +1,165.4% -84.6% +49.2% -64.6% +1,848.3%
– +92,837.8% – -9.3% -85.0% -872.8% – -223.0% -59.4% +360.0% – -1,552.7%
– – – – – – – – – – – –
– +519.2% -83.7% +189.4% +7.2% +18.3% +54.0% +4.1% – – – –
– – +0.0% +0.0% -1.5% -103.1% – – – – – –
– +422.0% -83.7% +189.4% +43.2% -12.2% +55.4% +4.1% -57.1% +212.4% -52.9% +806.0%
– +280.4% -150.2% – +212.9% -117.5% – -55.2% -188.8% – -783.9% –
– – – – – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?